0.722
price down icon6.12%   -0.0471
after-market Handel nachbörslich: .72 -0.002 -0.28%
loading
Schlusskurs vom Vortag:
$0.7691
Offen:
$0.751
24-Stunden-Volumen:
552.27K
Relative Volume:
1.32
Marktkapitalisierung:
$66.78M
Einnahmen:
$5.12M
Nettoeinkommen (Verlust:
$-67.00M
KGV:
-0.4912
EPS:
-1.47
Netto-Cashflow:
$-38.94M
1W Leistung:
-9.54%
1M Leistung:
+23.46%
6M Leistung:
+0.80%
1J Leistung:
-89.77%
1-Tages-Spanne:
Value
$0.70
$0.79
1-Wochen-Bereich:
Value
$0.70
$0.89
52-Wochen-Spanne:
Value
$0.3816
$7.80

Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile

Name
Firmenname
Verrica Pharmaceuticals Inc
Name
Telefon
484-453-3300
Name
Adresse
10 NORTH HIGH STREET, WEST CHESTER, PA
Name
Mitarbeiter
71
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-11
Name
Neueste SEC-Einreichungen
Name
VRCA's Discussions on Twitter

Vergleichen Sie VRCA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VRCA
Verrica Pharmaceuticals Inc
0.722 73.82M 5.12M -67.00M -38.94M -1.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-06 Herabstufung H.C. Wainwright Buy → Neutral
2024-11-05 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2023-07-25 Hochstufung Needham Hold → Buy
2023-03-22 Eingeleitet Jefferies Buy
2023-02-13 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2022-05-25 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2021-05-14 Eingeleitet RBC Capital Mkts Outperform
2020-12-24 Bestätigt H.C. Wainwright Buy
2020-07-15 Herabstufung BofA Securities Buy → Neutral
2020-06-30 Bestätigt H.C. Wainwright Buy
2020-06-24 Eingeleitet Northland Capital Outperform
2020-03-24 Eingeleitet Needham Buy
2019-02-21 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Verrica Pharmaceuticals Inc Aktie (VRCA) Neueste Nachrichten

pulisher
Jul 22, 2025

Verrica Pharmaceuticals Inc. Stock Analysis and ForecastHigh-velocity capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Verrica Pharmaceuticals Inc. stock priceFree Predictions - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Verrica Pharmaceuticals Inc. a good long term investmentHigh-impact investment strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

What analysts say about Verrica Pharmaceuticals Inc. stockMassive wealth growth - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 19, 2025

Published on: 2025-07-19 07:38:47 - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Is Verrica Pharmaceuticals Inc. stock overhyped or has real potentialAnalyst Grade Signals - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

What institutions are buying Verrica Pharmaceuticals Inc. stock nowDaily Trade Opportunity - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Verrica Pharmaceuticals Inc. stock price move sharplyInsider Strategy Insight - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Verrica Pharmaceuticals Inc. stock attracts strong analyst attentionFree Low-Risk Investment Plans - newser.com

Jul 15, 2025
pulisher
Jul 15, 2025

How Verrica Pharmaceuticals Inc. stock performs during market volatilityFree Stock Trading Community - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Receives $8.00 Average Target Price from Brokerages - Defense World

Jul 14, 2025
pulisher
Jul 10, 2025

Verrica Reports Strong Q2 Growth as YCANTH Demand Accelerates - MyChesCo

Jul 10, 2025
pulisher
Jul 10, 2025

Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025 - GlobeNewswire

Jul 10, 2025
pulisher
Jul 10, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Shares Down 4.9% – Should You Sell? - Defense World

Jul 10, 2025
pulisher
Jul 10, 2025

Verrica Pharmaceuticals reports 32.8% quarterly growth in YCANTH sales By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 09, 2025

Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025 | VRCA Stock News - GuruFocus

Jul 09, 2025
pulisher
Jul 09, 2025

Verrica Pharmaceuticals reports 32.8% quarterly growth in YCANTH sales - Investing.com

Jul 09, 2025
pulisher
Jul 02, 2025

Verrica Pharmaceuticals Advances Global Phase 3 Trial for YCANTH with Amended Torii Agreement - MyChesCo

Jul 02, 2025
pulisher
Jul 01, 2025

Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Commo - GuruFocus

Jul 01, 2025
pulisher
Jul 01, 2025

Verrica Pharmaceuticals Receives Milestone Payments and Initiates Global Phase 3 Trial for YCANTH® Treatment of Common Warts - Quiver Quantitative

Jul 01, 2025
pulisher
Jul 01, 2025

Verrica to receive $18 million in milestone payments from Torii in 2025 - Investing.com UK

Jul 01, 2025
pulisher
Jun 18, 2025

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Sees Significant Decline in Short Interest - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

Verrica Pharmaceuticals Reports Third Quarter 2021 Financial Results - Barchart.com

Jun 18, 2025
pulisher
Jun 16, 2025

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Given Average Recommendation of “Hold” by Brokerages - Defense World

Jun 16, 2025
pulisher
Jun 13, 2025

Shareholders May Not Overlook Verrica Pharmaceuticals Insiders Selling US$1.1m In Stock - simplywall.st

Jun 13, 2025
pulisher
Jun 12, 2025

Verrica Pharmaceuticals amends credit agreement By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Verrica Pharmaceuticals Amends Credit Agreement with OrbiMed - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Verrica Pharmaceuticals amends credit agreement - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA): Are Analysts Optimistic? - Yahoo Finance

Jun 12, 2025
pulisher
Jun 10, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Shares Up 0% – Here’s Why - Defense World

Jun 10, 2025
pulisher
Jun 05, 2025

Verrica Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks

Jun 05, 2025
pulisher
May 30, 2025

Verrica Pharmaceuticals to Present at Jefferies Global Healthcare Conference - MSN

May 30, 2025

Finanzdaten der Verrica Pharmaceuticals Inc-Aktie (VRCA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):